New TB treatment regimen introduced
The Hindu
THOOTHUKUDI
THOOTHUKUDI
The Government Medical College Hospital has introduced a new treatment regimen for treating the MDRTB (Multidrug Resistant Tuberculosis) patients, which costs up to Rs. 5 lakh in the private hospitals.
Dean Nehru launched the programme on Wednesday under the National Tuberculosis Elimination Programme (NTEB) by administering Shorter Oral Bedaquiline of MDRTB regimen to a patient.
According to Dr. Nehru, World Health Organization (WHO) and Central TB Division (CTD) guidelines are stipulating needleless treatment method, which has been introduced with newer and effective drug and the duration of the treatment lasts up to 11 months. MDRTB can be completely cured if the medication is taken regularly for the full duration as prescribed by the physician.
“The treatment, which costs around Rs. 5 lakh, is provided for all eligible MDRTB patients free of cost,” Dr. Nehru said.
Deputy Director (Tuberculosis) Sundaralingam said that this latest treatment regimen would create TB-free Tamil Nadu by 2025.
Resident Medical Officer, TKMCH, Silas Jayamani, Deputy Superintendent Kumaran, Head of the Department of Thoracic Medicine, Sangamitra, and Medical Officer, TB Cell, Kather Mohaideen Sheriff were present.

‘Instead of accusing Gen-Z of lacking skills or discipline, we need to ask what drives them’ Premium
At a recent event held in the city, Cambridge University Press & Assessment launched an advisory panel comprising leaders from top global corporations, aiming to bridge the employability gap in India and better align academic output with industry needs. A whitepaper released at the event highlighted the growing importance of communication skills, the need for stronger collaboration between industry and universities, and strategies to bridge the persistent skill gap.

Under the NBS, newborns are screened for communication disorders before they are discharged from the hospital. For this, AIISH has collaborated with several hospitals to conduct screening which is performed to detect hearing impairment and other developmental disabilities that can affect speech and language development. The screening has been helping in early intervention for those identified with the disorders, as any delay in the identification poses risk and affects successful management of children with hearing loss, according to AIISH.